menu
    • menu

    Company profile for Baymedica

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BayMedica is developing an efficient and scalable biosynthetic platform to deliver a portfolio of natural cannabinoids including CBC, CBN and CBG as well as novel cannabinoid analogs for life science, pharmaceutical, nutraceutical, cosmetic and animal health applications. We are developing the BayMedica platform and process to bring the benefits of cannabinoids to consumers and animals without the drawbacks of traditional meth...
    BayMedica is developing an efficient and scalable biosynthetic platform to deliver a portfolio of natural cannabinoids including CBC, CBN and CBG as well as novel cannabinoid analogs for life science, pharmaceutical, nutraceutical, cosmetic and animal health applications. We are developing the BayMedica platform and process to bring the benefits of cannabinoids to consumers and animals without the drawbacks of traditional methods that involve extracting these therapeutic compounds from cannabis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BaymedicaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    458 Carlton Ct. South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.baymedica.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InMed shares jump 8% after completing BayMedica deal
    InMed shares jump 8% after completing BayMedica deal

    13 Oct 2021

    // Aakash Babu SEEKINGALPHA

    https://seekingalpha.com/news/3752608-inmed-shares-jump-8-after-completing-baymedica-deal

    Aakash Babu SEEKINGALPHA
    13 Oct 2021
    Share Share
    InMed and BayMedica Participating in Tribe Public’s Webinar
    InMed and BayMedica Participating in Tribe Public’s Webinar

    17 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/17/2299022/36215/en/InMed-Pharmaceuticals-and-BayMedica-Participating-in-Tribe-Public-s-Webinar-Accelerating-The-Commercialization-of-Rare-Cannabinoids.html

    GLOBENEWSWIRE
    17 Sep 2021
    Share Share
    InMed Signs Non-binding Letter of Intent to Acquire BayMedica
    InMed Signs Non-binding Letter of Intent to Acquire BayMedica

    29 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/29/2254573/36215/en/InMed-Pharmaceuticals-Signs-Non-binding-Letter-of-Intent-to-Acquire-BayMedica-a-Commercial-Manufacturer-of-Rare-Cannabinoids.html

    GLOBENEWSWIRE
    29 Jun 2021
    Share Share
    InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica
    InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica

    29 Jun 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/inmed-pharmaceuticals-signs-non-binding-letter-of-intent-to-acquire-baymedica-a-commercial-manufacturer-of-rare-cannabinoids/?s=79

    BIOSPACE
    29 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search